|1.||Navarrete-Dechent, Cristián: 1 article (07/2015)|
|2.||González, Sergio: 1 article (07/2015)|
|3.||Jaque, Alejandra: 1 article (07/2015)|
|4.||Puerto, Constanza del: 1 article (07/2015)|
|5.||Marghoob, Ashfaq A: 1 article (07/2015)|
|6.||Bajaj, Shirin: 1 article (07/2015)|
|7.||Bugamelli, F: 1 article (02/2015)|
|8.||Gurioli, C: 1 article (02/2015)|
|9.||Neri, I: 1 article (02/2015)|
|10.||Saracino, M A: 1 article (02/2015)|
02/01/2014 - "Elastosis perforans serpiginosa is a rare skin disease characterized by transepidermal elimination of abnormal elastic fibers. "
01/01/2014 - "Elastosis perforans serpiginosa is a rare skin disease in which abnormal elastic fibers, other connective tissue elements, and cellular debris are expelled from the papillary dermis through the epidermis. "
10/01/2013 - "Elastosis perforans serpiginosa is a form of perforating dermatoses, which has a characteristic clinical presentation of grouped keratotic papules coalescing into serpiginous or annular configurations. "
11/01/2010 - "Elastosis perforans serpiginosa (EPS) is a rare reactive perforating dermatosis that is characterized by the transepidermal elimination of abnormal elastic fibers. "
09/01/2010 - "Elastosis perforans serpiginosa is a rare, primary perforating dermatosis, frequently associated with certain genetic diseases and characterized by the transepidermal extrusion of elastic fibers. "
|2.||Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome)
02/01/2015 - "To detect DPA in biopsy specimens in a unique case of 25-year-late-onset elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum associated with a history of long-term high dose DPA, by applying a recently described analytical method to assess the presence of DPA in skin. "
12/01/2009 - "The association between pseudoxanthoma elasticum and elastosis perforans serpiginosa was reported in two cases. "
05/01/2009 - "Recessive type 2 pseudoxanthoma elasticum is very rare and the presenting case is interesting in that this patient presented with lesions of secondary ossification and elastosis perforans serpiginosa in association with pseudoxanthoma elasticum."
09/01/2006 - "[Elastosis perforans serpiginosa in a patient with pseudoxanthoma elasticum]."
05/01/2005 - "Histopathology confirmed the diagnosis of elastosis perforans serpiginosa and pseudoxanthoma elasticum. "
|3.||Down Syndrome (Down's Syndrome)
09/01/2010 - "Elastosis perforans serpiginosa in a patient with Down's syndrome."
01/01/2006 - "A 12-year-old girl with trisomy 21 (Downs syndrome) presented with an approximate 2-year history of an asymptomatic eruption on the right upper arm and left lateral neck that was clinically and histologically diagnostic of elastosis perforans serpiginosa (EPS). "
01/01/2006 - "Elastosis perforans serpiginosa in a patient with trisomy 21."
07/01/2002 - "Elastosis perforans serpiginosa in an adult with Down's syndrome: report of a case with symmetrical localized involvement."
12/01/1997 - "Elastosis perforans serpiginosa can arise as a rare complication in patients with Down syndrome. "
04/01/1979 - "The clinical and histologic differential diagnosis is reviewed perforating folliculitis, reactive perforating collagenosis, and elastosis perforans serpiginosa. "
08/01/2008 - "Acquired perforating dermatosis appearing as elastosis perforans serpiginosa and perforating folliculitis."
10/01/2013 - "They include Kyrle's disease, perforating folliculitis, reactive perforating collagenosis, and elastosis perforans serpiginosa. "
07/01/2006 - "Clinical and histological features of the disease are not uniform, and may resemble any of the four classic perforating disorders: elastosis perforans serpiginosa, reactive perforating collagenosis, perforating folliculitis or Kyrle's disease. "
03/01/2005 - "Perforating disorders are uncommon diseases characterized by transepidermal elimination histopathologically and include reactive perforating collagenosis, elastosis perforans serpiginosa, Kyrle's disease and perforating folliculitis. "
|5.||Hepatolenticular Degeneration (Wilson's Disease)
03/01/2000 - "Pencillamine-induced elastosis perforans serpiginosa and cutis laxa in Wilson's disease."
08/01/2002 - "Elastosis perforans serpiginosa secondary to D-penicillamine treatment in a Wilson's disease patient."
05/01/1977 - "A patient with Wilson disease, under prolonged treatment with penicillamine, developed lesions of elastosis perforans serpiginosa (EPS). "
11/01/1973 - "Elastosis perforans serpiginosa during penicillamine therapy for Wilson disease."
01/01/2011 - "Long term D-penicillamine (DPA) therapy to treat Wilson disease can induce elastosis perforans serpiginosa (EPS), a very rare degenerative skin disease characterized by a transepidermal elimination of elastic fiber aggregates. "
|5.||Biological Markers (Surrogate Marker)
|6.||Growth Hormone (Somatotropin)
|1.||Renal Dialysis (Hemodialysis)